• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过成纤维细胞激活蛋白成像技术动态可视化急性肾损伤后的促纤维化适应性修复。

Dynamically visualizing profibrotic maladaptive repair after acute kidney injury by fibroblast activation protein imaging.

机构信息

Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Nephrology, Guangdong Provincial Clinical Research Center for Kidney Disease, Guangzhou, China; Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangdong Medical Products Administration Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Guangzhou, China.

Department of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou, China.

出版信息

Kidney Int. 2024 Nov;106(5):826-839. doi: 10.1016/j.kint.2024.07.015. Epub 2024 Aug 3.

DOI:10.1016/j.kint.2024.07.015
PMID:39098582
Abstract

A major challenge in prevention and early treatment of organ fibrosis is the lack of valuable tools to assess the evolving profibrotic maladaptive repair after injury in vivo in a non-invasive way. Here, using acute kidney injury (AKI) as an example, we tested the utility of fibroblast activation protein (FAP) imaging for dynamic assessment of maladaptive repair after injury. The temporospatial pattern of kidney FAP expression after injury was first characterized. Single-cell RNA sequencing and immunostaining analysis of patient biopsies were combined to show that FAP was specifically upregulated in kidney fibroblasts after AKI and was associated with fibroblast activation and chronic kidney disease (CKD) progression. This was corroborated in AKI mouse models, where a sustained and exaggerated kidney FAP upregulation was coupled to persistent fibroblast activation and a fibrotic outcome, linking kidney FAP level to post-insult maladaptive repair. Furthermore, using positron emission tomography (PET)/CT scanning with FAP-inhibitor tracers ([F]FAPI-42, [F]FAPT) targeting FAP, we demonstrated the feasibility of non-invasively tracking of maladaptive repair evolution toward kidney fibrosis. Importantly, a sustained increase in kidney [F]FAPT (less hepatobiliary metabolized than [F]FAPI-42) uptake reflected persistent kidney upregulation of FAP and characterized maladaptive repair after AKI. Kidney [F]FAPT uptake at hour 2-day 7 correlated with kidney fibrosis 14 days after AKI. Similar changes in [F]FAPI-42 PET/CT imaging were observed in patients with AKI and CKD progression. Thus, persistent kidney FAP upregulation after AKI was associated with maladaptive repair and a fibrotic outcome. Hence, FAP-specific PET/CT imaging enables dynamic visualization of maladaptive repair after AKI and prediction of kidney fibrosis within a clinically actionable window.

摘要

器官纤维化的预防和早期治疗的主要挑战是缺乏有价值的工具来无创地评估损伤后体内进行性的致纤维化适应性修复。在这里,我们以急性肾损伤 (AKI) 为例,测试了成纤维细胞激活蛋白 (FAP) 成像用于评估损伤后适应性修复的效用。首先描述了损伤后肾脏 FAP 表达的时空模式。对患者活检的单细胞 RNA 测序和免疫染色分析结合表明,FAP 在 AKI 后在肾脏成纤维细胞中特异性上调,并与成纤维细胞激活和慢性肾脏病 (CKD) 进展相关。在 AKI 小鼠模型中得到了证实,其中肾脏 FAP 的持续和夸大上调与持续的成纤维细胞激活和纤维化结果相关,将肾脏 FAP 水平与损伤后适应性修复联系起来。此外,使用针对 FAP 的 FAP 抑制剂示踪剂 ([F]FAPI-42、[F]FAPT) 的正电子发射断层扫描 (PET)/CT 扫描,我们证明了非侵入性跟踪向肾脏纤维化的适应性修复演变的可行性。重要的是,肾脏 [F]FAPT 摄取的持续增加(比 [F]FAPI-42 更少的肝内代谢)反映了肾脏 FAP 的持续上调,并在 AKI 后描述了适应性修复。AKI 后 2 天 7 小时的肾脏 [F]FAPT 摄取与 AKI 后 14 天的肾脏纤维化相关。在 AKI 和 CKD 进展的患者中观察到类似的 [F]FAPI-42 PET/CT 成像变化。因此,AKI 后肾脏 FAP 的持续上调与适应性修复和纤维化结果相关。因此,FAP 特异性 PET/CT 成像可实现 AKI 后适应性修复的动态可视化,并在临床可行的时间窗口内预测肾脏纤维化。

相似文献

1
Dynamically visualizing profibrotic maladaptive repair after acute kidney injury by fibroblast activation protein imaging.通过成纤维细胞激活蛋白成像技术动态可视化急性肾损伤后的促纤维化适应性修复。
Kidney Int. 2024 Nov;106(5):826-839. doi: 10.1016/j.kint.2024.07.015. Epub 2024 Aug 3.
2
Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study.成纤维细胞激活蛋白特异性 PET/CT 成像在肺纤维化性间质性肺疾病和肺癌中的应用:一项转化性探索性研究。
J Nucl Med. 2022 Jan;63(1):127-133. doi: 10.2967/jnumed.121.261925. Epub 2021 Jul 16.
3
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging.通过成纤维细胞激活蛋白成像对炎症与纤维化疾病活动进行区分。
Ann Rheum Dis. 2020 Nov;79(11):1485-1491. doi: 10.1136/annrheumdis-2020-217408. Epub 2020 Jul 21.
4
Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [F]-labeled glycopeptide-containing FAPI with [F]FAPI-42.利用正电子发射断层扫描术对 FAP 表达进行无创成像:[F]-标记的含糖肽 FAPI 与 [F]FAPI-42 的比较评估。
Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3363-3374. doi: 10.1007/s00259-023-06282-5. Epub 2023 Jun 2.
5
IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.IDH 野生型胶质母细胞瘤和 3/4 级 IDH 突变型胶质瘤在成纤维细胞激活蛋白特异性 PET/CT 中呈现出摄取增高。
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2569-2580. doi: 10.1007/s00259-019-04444-y. Epub 2019 Aug 6.
6
Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy.镓-成纤维细胞激活蛋白抑制剂 PET/CT 提高了对中低度肉瘤的检测能力,并确定了放射性药物治疗的候选者。
J Nucl Med. 2024 Jun 3;65(6):880-887. doi: 10.2967/jnumed.123.267248.
7
Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.镓-FAPI PET/CT:不同癌症患者中两种含 DOTA 的 FAP 靶向剂的生物分布和初步剂量估算。
J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2.
8
A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.短暂的白藜芦醇处理可预防肾缺血再灌注损伤后的适应性修复和大鼠的长期慢性肾脏病。
J Physiol. 2024 Apr;602(8):1835-1852. doi: 10.1113/JP285979. Epub 2024 Mar 26.
9
Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an F-Labeled FAP Inhibitor.靶向成纤维细胞激活蛋白:F 标记的 FAP 抑制剂的放射性合成与初步临床评估。
J Nucl Med. 2020 Dec;61(12):1806-1813. doi: 10.2967/jnumed.120.242958. Epub 2020 Apr 24.
10
[FAPI-PET-CT for quantification of the tissue response in rheumatic diseases].[用于定量评估风湿性疾病组织反应的FAPI-PET-CT]
Z Rheumatol. 2024 Aug;83(6):455-459. doi: 10.1007/s00393-024-01536-5. Epub 2024 Jul 20.

引用本文的文献

1
Molecular mechanisms and therapeutic advances of peritubular capillary neogenesis in acute kidney injury.急性肾损伤时肾小管周围毛细血管新生的分子机制与治疗进展
Front Mol Biosci. 2025 Aug 20;12:1643838. doi: 10.3389/fmolb.2025.1643838. eCollection 2025.
2
Advancements in the non-invasive diagnosis of renal fibrosis.肾纤维化的非侵入性诊断进展
Front Med (Lausanne). 2025 Jul 30;12:1646412. doi: 10.3389/fmed.2025.1646412. eCollection 2025.
3
Progress and applications of single-cell RNA sequencing and spatial transcriptome technology in acute kidney injury research.
单细胞RNA测序和空间转录组技术在急性肾损伤研究中的进展与应用
Mol Ther Nucleic Acids. 2025 May 30;36(3):102583. doi: 10.1016/j.omtn.2025.102583. eCollection 2025 Sep 9.
4
Noninvasive diagnosis and classification of kidney transplantation rejection by F-FAPI-04 PET/CT.通过F-FAPI-04 PET/CT对肾移植排斥反应进行无创诊断和分类
Eur J Nucl Med Mol Imaging. 2025 May 8. doi: 10.1007/s00259-025-07307-x.